相关实验视频

Updated: May 1, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

在多发性骨髓瘤中针对B细胞成熟抗原的PET/CT成像:这是首次对人类进行研究

Tingfei Gu¹, Zhao Chen¹, Tianyao Wang¹

¹Department of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str., Xicheng Dist, Beijing, 100034, China.

Journal of hematology & oncology

|November 14, 2025

概括

针对B细胞成熟抗原 (BCMA) 的新型PET/CT扫描显示,与标准方法相比,多发性骨髓瘤病变的检测有所改善. 这种非侵入性成像可能有助于指导治疗,特别是在CAR-T治疗中.

科学领域:

核医学是一种核医学.
在瘤学瘤学.
免疫治疗是一种免疫疗法.

背景情况:

B细胞成熟抗原 (BCMA) 是多发性骨髓瘤 (MM) 治疗的目标.
传统的18F-FDG PET/CT对MM的特异性和采样有局限性.
骨髓活检是侵入性的,并提供焦点采样.

研究的目的:

在MM管理中评估一种新的68Ga标记的基于纳米体的PET/CT的BCMA追踪器.
为了比较BCMA immunoPET与18F-FDG PET/CT的诊断性能.
评估BCMA immunoPET在检测各种损伤类型和最小残留疾病 (MRD) 的潜力.

主要方法:

使用68Ga标记的基于纳米体的BCMA追踪器进行前性研究.
与传统的18F-FDG PET/CT成像技术进行比较.
测量器可视化骨髓,骨髓外和骨髓外病变以及MRD的能力的评估.

主要成果:

与18F-FDG PET/CT相比,BCMA追踪器证明了对MM病变的检测有所改善.
成功可视化了甲骨髓,外骨髓和骨髓损伤.
检测到最小残留性疾病 (MRD),并反映了BCMA表达与治疗的动态变化.

结论:

BCMA immunoPET是一种有前途的非侵入性工具,用于全面的MM评估.
追踪器检测病变和MRD的能力支持其在指导BCMA向疗法的实用性,包括CAR-T.
需要在更大的前性临床试验中进一步验证.

关键词:

在B细胞成熟抗原.最少残留疾病的最小残留疾病.多发性骨髓瘤是一种多发性骨髓瘤.聚乙烯/聚乙烯/聚乙烯治疗监测治疗的监测.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET